145 related articles for article (PubMed ID: 25614433)
1. Could late enhancement and need for permanent pacemaker implantation in patients undergoing TAVR be explained by undiagnosed transthyretin cardiac amyloidosis?
Castaño A; Bokhari S; Maurer MS
J Am Coll Cardiol; 2015 Jan; 65(3):311-2. PubMed ID: 25614433
[No Abstract] [Full Text] [Related]
2. Reply: could late enhancement and need for permanent pacemaker implantation in patients undergoing TAVR be explained by undiagnosed transthyretin cardiac amyloidosis?
Siontis GC; Windecker S
J Am Coll Cardiol; 2015 Jan; 65(3):313. PubMed ID: 25614435
[No Abstract] [Full Text] [Related]
3. Reply: could late enhancement and need for permanent pacemaker implantation in patients undergoing TAVR be explained by undiagnosed transthyretin cardiac amyloidosis?
Kim WK; Rolf A; Möllmann H
J Am Coll Cardiol; 2015 Jan; 65(3):312-3. PubMed ID: 25614434
[No Abstract] [Full Text] [Related]
4. Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A).
Elmariah S; Palacios IF; McAndrew T; Hueter I; Inglessis I; Baker JN; Kodali S; Leon MB; Svensson L; Pibarot P; Douglas PS; Fearon WF; Kirtane AJ; Maniar HS; Passeri JJ;
Circ Cardiovasc Interv; 2013 Dec; 6(6):604-14. PubMed ID: 24221391
[TBL] [Abstract][Full Text] [Related]
5. Permanent pacemaker implantation after transcatheter aortic valve implantation: impact on late clinical outcomes and left ventricular function.
Urena M; Webb JG; Tamburino C; Muñoz-García AJ; Cheema A; Dager AE; Serra V; Amat-Santos IJ; Barbanti M; Immè S; Briales JH; Benitez LM; Al Lawati H; Cucalon AM; García Del Blanco B; López J; Dumont E; Delarochellière R; Ribeiro HB; Nombela-Franco L; Philippon F; Rodés-Cabau J
Circulation; 2014 Mar; 129(11):1233-43. PubMed ID: 24370552
[TBL] [Abstract][Full Text] [Related]
6. Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis.
Siontis GC; Jüni P; Pilgrim T; Stortecky S; Büllesfeld L; Meier B; Wenaweser P; Windecker S
J Am Coll Cardiol; 2014 Jul; 64(2):129-40. PubMed ID: 25011716
[TBL] [Abstract][Full Text] [Related]
7. Time Course of Common Clinical Manifestations in Patients with Transthyretin Cardiac Amyloidosis: Delay From Symptom Onset to Diagnosis.
Papoutsidakis N; Miller EJ; Rodonski A; Jacoby D
J Card Fail; 2018 Feb; 24(2):131-133. PubMed ID: 29305186
[No Abstract] [Full Text] [Related]
8. Comparison between (99m)Tc-diphosphonate imaging and MRI with late gadolinium enhancement in evaluating cardiac involvement in patients with transthyretin familial amyloid polyneuropathy.
Minutoli F; Di Bella G; Mazzeo A; Donato R; Russo M; Scribano E; Baldari S
AJR Am J Roentgenol; 2013 Mar; 200(3):W256-65. PubMed ID: 23436870
[TBL] [Abstract][Full Text] [Related]
9. Update on the need for a permanent pacemaker after transcatheter aortic valve implantation using the CoreValve® Accutrak™ system.
Tchetche D; Modine T; Farah B; Vahdat O; Sudre A; Koussa M; Lereun C; Nejjari M; Choby M; Rosencher J; Sorbets E; Fajadet J
EuroIntervention; 2012 Sep; 8(5):556-62. PubMed ID: 22995081
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of persistent left bundle-branch block after transcatheter aortic valve implantation with CoreValve Revalving System.
Testa L; Latib A; De Marco F; De Carlo M; Agnifili M; Latini RA; Petronio AS; Ettori F; Poli A; De Servi S; Ramondo A; Napodano M; Klugmann S; Ussia GP; Tamburino C; Brambilla N; Colombo A; Bedogni F
Circulation; 2013 Mar; 127(12):1300-7. PubMed ID: 23443735
[TBL] [Abstract][Full Text] [Related]
11. Perioperative conduction disturbances after transcatheter aortic valve replacement.
Ghadimi K; Patel PA; Gutsche JT; Sophocles A; Anwaruddin S; Szeto WY; Augoustides JG
J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1414-20. PubMed ID: 24103715
[TBL] [Abstract][Full Text] [Related]
12. Endovascular transcatheter aortic valve implantation: an evolving standard.
Sfeir PM; Abchee AB; Ghazzal Z; Beresian J; Gellad P; Ayoub CM
J Cardiothorac Vasc Anesth; 2013 Aug; 27(4):765-78. PubMed ID: 23266289
[No Abstract] [Full Text] [Related]
13. Frequency of conduction disturbances after Edwards SAPIEN percutaneous valve implantation.
Laynez A; Ben-Dor I; Barbash IM; Hauville C; Sardi G; Maluenda G; Xue Z; Satler LF; Pichard AD; Lindsay J; Waksman R
Am J Cardiol; 2012 Oct; 110(8):1164-8. PubMed ID: 22770935
[TBL] [Abstract][Full Text] [Related]
14. Cardiac amyloidosis: updates in diagnosis and management.
Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
[TBL] [Abstract][Full Text] [Related]
15. A representative case of hereditary transthyretin amyloidosis complicated by intramyocardial hemorrhage.
Yagi H; Amiya E; Shintani Y; Nitta D; Numakura S; Hosoya Y; Watanabe M; Fukayama M; Komuro I
Amyloid; 2015 Mar; 22(1):70-2. PubMed ID: 25427692
[No Abstract] [Full Text] [Related]
16. Incidence and predictors of permanent pacemaker implantation following transcatheter aortic valve implantation: analysis from the German transcatheter aortic valve interventions registry.
Ledwoch J; Franke J; Gerckens U; Kuck KH; Linke A; Nickenig G; Krülls-Münch J; Vöhringer M; Hambrecht R; Erbel R; Richardt G; Horack M; Zahn R; Senges J; Sievert H;
Catheter Cardiovasc Interv; 2013 Oct; 82(4):E569-77. PubMed ID: 23475694
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and Treatment of Transthyretin Cardiac Amyloidosis. Progress and Hope.
González-López E; López-Sainz Á; Garcia-Pavia P
Rev Esp Cardiol (Engl Ed); 2017 Nov; 70(11):991-1004. PubMed ID: 28870641
[TBL] [Abstract][Full Text] [Related]
18. Permanent pacemaker implantation after isolated aortic valve replacement.
Talwar S; Choudhary SK; Kumar AS
Ann Thorac Surg; 2008 Oct; 86(4):1403. PubMed ID: 18805222
[No Abstract] [Full Text] [Related]
19. Severe aortic stenosis and coronary artery disease--implications for management in the transcatheter aortic valve replacement era: a comprehensive review.
Goel SS; Ige M; Tuzcu EM; Ellis SG; Stewart WJ; Svensson LG; Lytle BW; Kapadia SR
J Am Coll Cardiol; 2013 Jul; 62(1):1-10. PubMed ID: 23644089
[TBL] [Abstract][Full Text] [Related]
20. Permanent pacemaker implantation after isolated aortic valve replacement: incidence, indications, and predictors.
Dawkins S; Hobson AR; Kalra PR; Tang AT; Monro JL; Dawkins KD
Ann Thorac Surg; 2008 Jan; 85(1):108-12. PubMed ID: 18154792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
